Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NPS, Nycomed in Gattex deal

NPSP granted Nycomed (Zurich, Switzerland) exclusive rights to develop and commercialize Gattex teduglutide

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE